## BLK: BlackRock, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 3.4% below STRENGTH zone (4.0-10.0%); PEG 1.94 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1080.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Key facts: BlackRock's $2.3B BUIDL fund targets asset tokenization; Announces municipal fund distribution**
- Source: TradingView â€” Track All Markets | 20260103T200740 | Bullish | Relevance: 100%
- BlackRock's BUIDL fund, valued at $2.3 billion, is focused on the tokenization of real-world assets and integrating digital assets into mainstream financial markets. Additionally, BlackRock has revealed the distribution dates and specific amounts for several of its municipal closed-end funds.

**2. Investment Research & Advisory Group Inc. Makes New Investment in BlackRock $BLK**
- Source: MarketBeat | 20260105T125208 | Somewhat-Bullish | Relevance: 100%
- Investment Research & Advisory Group Inc. has made a new significant investment in BlackRock (NYSE:BLK), acquiring over 5,300 shares valued at approximately $6.2 million, making it a substantial holding in their portfolio. This investment comes amidst notable insider selling from BlackRock's CFO and a director, yet analysts largely maintain positive ratings with an average target price around $1,316. The article also highlights various institutional holdings and recent BlackRock news, including cryptocurrency-related activities and legal pressures.

**3. BlackRock (NYSE:BLK) Stock Rating Lowered by Wall Street Zen**
- Source: MarketBeat | 20260105T061230 | Neutral | Relevance: 100%
- Wall Street Zen has downgraded BlackRock (NYSE:BLK) from a "hold" to a "sell" rating, despite a broader analyst consensus of a "Moderate Buy" with an average price target of $1,316.18. The downgrade comes amid concerns about near-term risks such as crypto transfers and potential year-end outflows for Bitcoin/Ethereum spot ETFs, which could impact BlackRock's assets under management and fees, as well as legal exposure from a multi-state lawsuit regarding alleged influence on coal prices. BlackRock recently reported Q3 EPS of $11.55, missing estimates, though revenue of $6.51 billion surpassed expectations and rose 25.2% year-over-year.

**4. BlackRock $BLK Shares Sold by Asset Management One Co. Ltd.**
- Source: MarketBeat | 20260104T095049 | Neutral | Relevance: 100%
- Asset Management One Co. Ltd. reduced its stake in BlackRock ($BLK) by 4.2% in Q3, selling 2,767 shares, though other major institutions significantly increased their positions, indicating strong institutional demand. BlackRock's Q3 revenue rose 25.2% year-over-year, but EPS slightly missed estimates, and the company faces near-term risks from crypto flow volatility and a multi-state lawsuit. Analysts are largely bullish on BlackRock, with an average target price of around $1,316, despite recent insider share sales.

**5. PNC's new president on what lured him from BlackRock after 21 years (Newly Minted)**
- Source: The Business Journals | 20260103T130839 | Neutral | Relevance: 82%
- Mark Wiedman, who recently became president of PNC after 21 years at BlackRock, revealed the specific factors that drew him to PNC. He had originally planned on becoming an entrepreneur, but PNC's opportunities ultimately swayed his decision.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Keefe, Bruyette | $1322 | $1390 | -5% |
| 2025-12-17 | Morgan Stanley | $1514 | $1486 | +2% |
| 2025-12-12 | Barclays | $1340 | $1360 | -1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Keefe, Bruyette | main | Outperform |
| 2025-12-17 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 8.9% (-1.1%)
- Blackrock Inc.: 6.5% (-0.4%)
- State Street Corpora: 4.0% (-0.7%)
- Temasek Holdings (Pr: 3.3% (0.0%)
- Bank of America Corp: 3.3% (+4.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +2.5% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.94 elevated, pricing in significant growth expectations. Quality metrics strong (margin 27%). Balance sheet: strong liquidity (14.4x), $1.3B free cash flow. Analyst sentiment negative (2 target cuts vs 1 raises). Institutional flow bearish (7 selling vs 2 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $173.7B |
| Beta | 1.48 |
| 52W Range | $773.74 - $1219.94 |
| Short Interest | 0.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.94 |
| Forward P/E | 20.8 |
| Current P/E | 23.5 |
| YoY Growth | 12.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.0% to 3.4% (+2.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.6pp (needs >4.0% for momentum thesis). MRS_5 at 2.6% confirms short-term momentum alignment. AM_20 at 3.6% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.10), confirming momentum. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.44% (CS: 76) | Neutral |
| RSI_14 | 64.1 | Neutral |
| MACD Histogram | 3.10 | Bullish |
| vs SMA20 | 1.036x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 1.066x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1119.71
- **Stop Loss:** $1080.45 (3.5% risk)
- **Target:** $1158.97 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 35
- **Position Value:** $39,189.85
- **Portfolio %:** 39.19%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-14 (Est: $12.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $11.34 | $11.55 | +1.9% |
| 2025Q2 | $10.81 | $12.05 | +11.5% |
| 2025Q1 | $10.13 | $11.30 | +11.6% |
| 2024Q4 | $11.22 | $11.93 | +6.4% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*